Remove asia-s-rise-in-the-global-pharma-industry
article thumbnail

Pharmaceutical excipients market to witness expansion

European Pharmaceutical Review

Excipients market opportunities and limitations Major contributing factors regarding growth of the pharmaceutical excipients market are: increasing demand for generic drugs and drug products, increased investment in R&D for the development of novel excipients and rising emphasis on patient-centric formulations.

article thumbnail

Pharma contract manufacturing market to grow to $130bn by 2026

European Pharmaceutical Review

Rising demand for therapeutics, especially in developing markets, is expected to expand the global pharmaceutical contract manufacturing market to $130.2 Based on region, China, the world`s second largest economy, is forecast to reach a projected market size of $21.1 billion by 2026. Within the $130.2 percent CAGR. percent, 4.1

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

ICON biotech sector survey: Insights and projections shaping the Industry

PM360

The landscape of the biotech industry is a dynamic canvas, shaped by innovation, funding, and the pursuit of ground-breaking solutions. The ICON Biotech 2023 sector survey shares insights from 133 biotech decision-makers based in North America, Europe, and Asia Pacific.

article thumbnail

Strengthening and transforming the pharmaceutical supply chain

European Pharmaceutical Review

Manufacturing delays and capacity issues that continue to impact the pharmaceutical supply chain have led to medicine shortages around the globe; an issue that has been exacerbated further by geopolitical events, the energy crisis and rising inflation. What are the top three supply-related challenges facing pharmaceutical manufacturers?

article thumbnail

The impact of clinical trial decentralisation on the pharma supply chain

Pharmaceutical Technology

But that is changing; technological and cultural shifts mean decentralised research – where part or all of a clinical trial is conducted remotely – is on the rise. Virtual trials increased 50% year on year between 2020 and 2021 and evidence suggests the frontiers of the global clinical trial map are expanding.

Pharma 59
article thumbnail

The impact of clinical trial decentralisation on the pharma supply chain

Pharmaceutical Technology

But that is changing; technological and cultural shifts mean decentralised research – where part or all of a clinical trial is conducted remotely – is on the rise. Virtual trials increased 50% year on year between 2020 and 2021 and evidence suggests the frontiers of the global clinical trial map are expanding.

Pharma 52